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	 Does	high	dietary	soy	intake	
affect	a	woman’s	risk	of	primary	
or	recurrent	breast	cancer?	
	 No,	 it	 doesn’t	 affect	 the	 risk	 of	
	 primary	 breast	 cancer,	 but	 it	
does	 (favorably)	 affect	 the	 risk	 of	 cancer	
recurrence.	
Compared	with	diets	low	in	soy,	high	
dietary	intake	of	soy	protein	or	soy	isofla-
vones	 isn’t	 associated	with	 any	 alteration	
in	 the	 risk	 of	 developing	 primary	 breast	
cancer	 (strength	 of	 recommendation	
[SOR]:	 B,	 systematic	 review	 of	 prospec-
tive	cohort	studies).	In	patients	with	breast	
cancer,	 however,	 consuming	 a	 diet	 high	
in	 soy	 is	 associated	 with	 a	 25%	 decrease	
in	 cancer	 recurrence	and	a	 15%	decrease	
in	mortality	 	 (SOR:	B,	 prospective	 cohort	
studies).	
Evidence summary 
A	 large	 systematic	 review	 evaluated	 the	 re-
lationship	 between	 dietary	 soy	 intake	 and	
risk	 of	 a	 primary	 breast	 cancer	 diagnosis.	 It	
included	7	prospective	cohort	studies,	which	
comprised	 the	 best	 quality	 evidence	 avail-
able	(numerous	other	reviewed	studies	were	
of	lower	quality).	The	review	found	no	signifi-
cant	 association	 between	 dietary	 soy	 intake	
and	primary	breast	cancer	(tABLE1-6).	
Investigators	 either	 surveyed	 women	
for	 intake	of	 soy	 isoflavones	 or	 soy	 foods	or	
products	 (tofu,	 soybeans,	 lentils,	 miso)	 or	
measured	urinary	or	plasma	levels	of	soy	iso-
flavones.	They	adjusted	 for	age,	alcohol	use,	
smoking	 status,	 body	 mass	 index,	 caloric	
intake,	 and	 hormone	 replacement	 therapy,	
then	followed	subjects	for	7	to	23	years,	com-
paring	the	risk	of	breast	cancer	for	the	lowest	
and	highest	levels	of	soy	intake.	
Six	 of	 the	 prospective	 cohort	 studies	
found	 no	 association	 between	 soy	 intake	
and	breast	cancer	risk;	one	study,	compris-
ing	4%	of	the	total	population,	found	a	lower	
risk	with	higher	soy	intake	(effect	size=0.44;	
95%	 confidence	 interval	 [CI],	 0.26-0.73;	 an	
effect	size	of	0.2	is	considered	small,	0.6	me-
dium,	and	1.2	 large).	The	authors	didn’t	do	
a	 meta-analysis	 of	 the	 prospective	 cohort	
studies.
Other cohort studies  
yield similar findings
Four	other	large	systematic	reviews	evaluating	
soy	intake	and	breast	cancer	risk	incorporated	
a	total	of	6	individual	prospective	cohort	stud-
ies	that	weren’t	included	in	the	previously	de-
scribed	review	(again,	these	studies	comprised	
the	best	quality	evidence	within	the	reviews).	
The	 6	 studies	 found	 no	 association	 between	
soy	intake	and	breast	cancer	risk.	
In	2	of	the	studies,	investigators	surveyed	
postmenopausal	 women	 and	 followed	 them	
for	4	to	8	years.2	Investigators	in	another	study	
adjusted	 for	age,	 family	and	gynecologic	his-
tory,	 hormone	 and	medication	use,	 exercise,	
and	 other	 factors.3	 In	 2	 other	 studies,	 inves-
tigators	 evaluated	 population	 subsets	 that	
consumed	the	most	vs	the	fewest	servings	per	
week	or	kilograms	per	year	of	soy	foods.4	The	
sixth	study	compared	low	with	high	intake	of	
soy	foods	and	miso.5
Soy intake after breast cancer diagnosis  
reduces recurrence risk in most studies
Most	 prospective	 cohort	 studies	 evaluating	
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Associated	risk	of	primary	or	recurrent	breast	cancer		
relative	to	soy	intake1-6
outcome Type of study Population comparison groups 
(highest vs lowest dietary 
intake of soy)
result (95% confidence 
interval)
Primary breast 
cancer incidence
Systematic review 
with 7 prospective 
cohort studies1
Western and asian 
women 
(N=~170,000)
highest vs lowest dietary 
intake of soy isoflavone, soy 
foods/products, or measured 
isoflavone levels
No overall difference  
in risk
2 prospective cohort 
studies2
american and Dutch 
postmenopausal 
women
(N=50,500)
highest vs lowest soy 
isoflavone intake and
soy supplementation  
vs no supplement 
No overall difference  
in risk in either study
1 prospective cohort 
study3 
Japanese women
(N=30,454)
highest vs lowest tertile,  
soy food intake
No overall difference  
in risk 
2 prospective cohort 
studies4
chinese women
(N=1800)
highest vs lowest soy food 
intake
No overall difference  
in risk 
1 prospective cohort 
study5
american and 
Japanese women
(N=178,000)
highest vs lowest soy food 
intake (tofu and miso)
No overall difference  
in risk 
breast cancer 
recurrence and 
breast cancer-
related mortality
meta-analysis of
5 prospective cohort 
studies6
chinese and 
american women 
with prior diagnosis 
of breast cancer 
(N=11,206)
Soy protein intake 
>13 g/d vs <2 g/d 
Soy isoflavones
>17 mg/d vs <7.6 mg/d      
Overall 
highest vs lowest dietary 
soy intake (pooled)
recurrence: hr=0.79  
(0.72–0.87); mortality: 
hr=0.85 (0.77–0.93)
Estrogen receptor positive 
highest vs lowest soy 
intake
recurrence: hr=0.81  
(0.63–1.04); mortality: 
hr=0.72 (0.61–0.84)* 
Estrogen receptor negative
highest vs lowest
recurrence: hr=0.64 
(0.44–0.94);*  mortality: 
hr=0.75 (0.64–0.88)*
hr, hazard ratio.
* Statistically significant.
the	 association	 between	 dietary	 soy	 intake	
after	breast	cancer	diagnosis	found	an	over-
all	 21%	 decrease	 in	 recurrence	 with	 high	
soy	intake	and	a	15%	reduction	in	mortality	
(tABLE1-6).	
Investigators	in	a	meta-analysis	of	5	stud-
ies	that	followed	women	for	4	to	7	years	after	
first	breast	cancer	diagnosis	found	that	higher	
soy	intake	was	associated	with	lower	mortality	
but	not	 less	 recurrence	 in	women	who	were	
estrogen	 receptor	 positive.	 Both	 recurrence	
and	mortality	were	decreased	in	estrogen	re-
ceptor	negative	women.6	
The	 study	 also	 found	 lower	 recurrence	
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and	 mortality	 in	 premenopausal	 women	
with	 higher	 soy	 intake	 (recurrence	 hazard	
ratio	 [HR]=0.91;	95%	CI,	0.72-1.14;	mortality	
HR=0.78;	 95%	 CI,	 0.69-0.88).	 In	 postmeno-
pausal	women,	higher	intake	was	likewise	as-
sociated	with	improvement	of	both	outcomes	
(recurrence	HR=0.67;	95%	CI,	0.56-0.80;	mor-
tality	HR=0.81;	95%	CI,	0.73-0.91).	
An	earlier	meta-analysis	of	4	prospective	
cohort	 studies,	 2	 of	which	were	not	 included	
above,	also	found	reduced	risk	of	breast	cancer	
recurrence	in	groups	with	high	vs	low	soy	iso-
flavone	 intake	 (HR=0.84;	 95%	 CI,	 0.70-0.99).7	
Women	 taking	 tamoxifen	 showed	 no	 differ-
ence	in	mortality	or	recurrence	risk	associated	
with	soy	intake.	
An	 additional	 small	 prospective	 cohort	
study	(n=256)	found	similar	reductions	in	re-
currence	and	mortality	associated	with	high-
er	consumption	of	soy	protein.8	              JFP 
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